339 related articles for article (PubMed ID: 16605240)
1. Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids.
Leung D; Saghatelian A; Simon GM; Cravatt BF
Biochemistry; 2006 Apr; 45(15):4720-6. PubMed ID: 16605240
[TBL] [Abstract][Full Text] [Related]
2. Characterization of mice lacking candidate N-acyl ethanolamine biosynthetic enzymes provides evidence for multiple pathways that contribute to endocannabinoid production in vivo.
Simon GM; Cravatt BF
Mol Biosyst; 2010 Aug; 6(8):1411-8. PubMed ID: 20393650
[TBL] [Abstract][Full Text] [Related]
3. Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway.
Simon GM; Cravatt BF
J Biol Chem; 2006 Sep; 281(36):26465-72. PubMed ID: 16818490
[TBL] [Abstract][Full Text] [Related]
4. Localization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain: A new perspective on N-acylethanolamines as neural signaling molecules.
Egertová M; Simon GM; Cravatt BF; Elphick MR
J Comp Neurol; 2008 Feb; 506(4):604-15. PubMed ID: 18067139
[TBL] [Abstract][Full Text] [Related]
5. Peripheral tissue levels and molecular species compositions of N-acyl-phosphatidylethanolamine and its metabolites in mice lacking N-acyl-phosphatidylethanolamine-specific phospholipase D.
Inoue M; Tsuboi K; Okamoto Y; Hidaka M; Uyama T; Tsutsumi T; Tanaka T; Ueda N; Tokumura A
J Biochem; 2017 Dec; 162(6):449-458. PubMed ID: 28992041
[TBL] [Abstract][Full Text] [Related]
6. Lipidomics profile of a NAPE-PLD KO mouse provides evidence of a broader role of this enzyme in lipid metabolism in the brain.
Leishman E; Mackie K; Luquet S; Bradshaw HB
Biochim Biophys Acta; 2016 Jun; 1861(6):491-500. PubMed ID: 26956082
[TBL] [Abstract][Full Text] [Related]
7. N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: a novel enzyme of the beta-lactamase fold family releasing anandamide and other N-acylethanolamines.
Ueda N; Okamoto Y; Morishita J
Life Sci; 2005 Aug; 77(14):1750-8. PubMed ID: 15949819
[TBL] [Abstract][Full Text] [Related]
8. New players in the fatty acyl ethanolamide metabolism.
Rahman IA; Tsuboi K; Uyama T; Ueda N
Pharmacol Res; 2014 Aug; 86():1-10. PubMed ID: 24747663
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmalogen through N-acylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent and -independent pathways.
Tsuboi K; Okamoto Y; Ikematsu N; Inoue M; Shimizu Y; Uyama T; Wang J; Deutsch DG; Burns MP; Ulloa NM; Tokumura A; Ueda N
Biochim Biophys Acta; 2011 Oct; 1811(10):565-77. PubMed ID: 21801852
[TBL] [Abstract][Full Text] [Related]
10. Mammalian cells stably overexpressing N-acylphosphatidylethanolamine-hydrolysing phospholipase D exhibit significantly decreased levels of N-acylphosphatidylethanolamines.
Okamoto Y; Morishita J; Wang J; Schmid PC; Krebsbach RJ; Schmid HH; Ueda N
Biochem J; 2005 Jul; 389(Pt 1):241-7. PubMed ID: 15760304
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic formation of anandamide.
Okamoto Y; Tsuboi K; Ueda N
Vitam Horm; 2009; 81():1-24. PubMed ID: 19647106
[TBL] [Abstract][Full Text] [Related]
12. Biosynthetic pathways of the endocannabinoid anandamide.
Okamoto Y; Wang J; Morishita J; Ueda N
Chem Biodivers; 2007 Aug; 4(8):1842-57. PubMed ID: 17712822
[TBL] [Abstract][Full Text] [Related]
13. Dietary fatty acids augment tissue levels of n-acylethanolamines in n-acylphosphatidylethanolamine phospholipase D (NAPE-PLD) knockout mice.
Lin L; Metherel AH; Kitson AP; Alashmali SM; Hopperton KE; Trépanier MO; Jones PJ; Bazinet RP
J Nutr Biochem; 2018 Dec; 62():134-142. PubMed ID: 30290332
[TBL] [Abstract][Full Text] [Related]
14. Mammalian enzymes responsible for the biosynthesis of N-acylethanolamines.
Hussain Z; Uyama T; Tsuboi K; Ueda N
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Dec; 1862(12):1546-1561. PubMed ID: 28843504
[TBL] [Abstract][Full Text] [Related]
15. Leptogenic effects of NAPE require activity of NAPE-hydrolyzing phospholipase D.
Chen Z; Zhang Y; Guo L; Dosoky N; de Ferra L; Peters S; Niswender KD; Davies SS
J Lipid Res; 2017 Aug; 58(8):1624-1635. PubMed ID: 28596183
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoid-related enzymes as drug targets with special reference to N-acylphosphatidylethanolamine-hydrolyzing phospholipase D.
Ueda N; Okamoto Y; Tsuboi K
Curr Med Chem; 2005; 12(12):1413-22. PubMed ID: 15974992
[TBL] [Abstract][Full Text] [Related]
17. Biosynthetic pathways of bioactive N-acylethanolamines in brain.
Tsuboi K; Ikematsu N; Uyama T; Deutsch DG; Tokumura A; Ueda N
CNS Neurol Disord Drug Targets; 2013 Feb; 12(1):7-16. PubMed ID: 23394527
[TBL] [Abstract][Full Text] [Related]
18. NAPE-PLD in the ventral tegmental area regulates reward events, feeding and energy homeostasis.
Castel J; Li G; Onimus O; Leishman E; Cani PD; Bradshaw H; Mackie K; Everard A; Luquet S; Gangarossa G
Mol Psychiatry; 2024 May; 29(5):1478-1490. PubMed ID: 38361126
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence-Based NAPE-PLD Activity Assay.
Mock ED; Driever WPF; van der Stelt M
Methods Mol Biol; 2023; 2576():233-240. PubMed ID: 36152191
[TBL] [Abstract][Full Text] [Related]
20. Formation of N-acyl-phosphatidylethanolamine and N-acylethanolamine (including anandamide) during glutamate-induced neurotoxicity.
Hansen HS; Moesgaard B; Hansen HH; Schousboe A; Petersen G
Lipids; 1999; 34 Suppl():S327-30. PubMed ID: 10419193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
